Detalles de la búsqueda
1.
Unconventional T Cells Influence Clinical Outcome After Allogeneic Hematopoietic Cell Transplantation.
J Clin Immunol
; 44(6): 139, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38822857
2.
Extracorporeal photopheresis as first-line strategy in the treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: A single-center experience.
Cytotherapy
; 22(8): 445-449, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32434750
3.
Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(7): 1407-1415, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30871978
4.
Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantation.
Eur J Haematol
; 103(1): 10-17, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30958904
5.
Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study.
Biol Blood Marrow Transplant
; 24(7): 1471-1475, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29477779
6.
Sequential Conditioning with Thiotepa in T Cell- Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated Donors.
Biol Blood Marrow Transplant
; 24(5): 1013-1021, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29337223
7.
Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemia.
Cancer
; 123(15): 2867-2874, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28387928
8.
Low incidence of hyperacute graft-versus-host disease (GVHD) with effective GVHD prophylaxis based on anti-thymocyte globulin.
Br J Haematol
; 197(5): 630-633, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35245388
9.
Infectious complications after post-transplantation cyclophosphamide and anti-thymocyte globulin-based haploidentical stem cell transplantation.
Br J Haematol
; 187(3): e64-e68, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31487392
10.
Human herpesvirus type 6 reactivation after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide and antithymocyte globulin: risk factors and clinical impact.
Clin Hematol Int
; 6(1): 26-38, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38817703
11.
A clinical trial combining megakaryocytes and haematopoietic stem cells to promote engraftment after autologous transplantation.
Br J Haematol
; 183(1): 139-142, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28891211
12.
Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation.
Bone Marrow Transplant
; 58(1): 61-67, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36224494
13.
Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation.
Bone Marrow Transplant
; 58(11): 1215-1222, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37596473
14.
Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies.
Bone Marrow Transplant
; 58(4): 386-392, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36585459
15.
Stable pulmonary function after haploidentical stem cell transplantation with post-transplant cyclophosphamide: a single center experience.
Leuk Lymphoma
; 63(2): 443-449, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34587856
16.
Thiotepa-busulfan-fludarabine as a conditioning regimen for patients with myelofibrosis undergoing allogeneic hematopoietic transplantation: a single center experience.
Leuk Lymphoma
; 62(2): 419-427, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33012207
17.
Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation.
JACC CardioOncol
; 3(2): 250-259, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34396331
18.
Delayed recovery after autologous peripheral hematopoietic cell transplantation: potential effect of a high number of total nucleated cells in the graft.
Transfusion
; 50(12): 2649-59, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20576009
19.
Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignancies.
Bone Marrow Transplant
; 55(4): 763-772, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31673080
20.
Tolerability and Efficacy of Treatment With Azacytidine as Prophylactic or Preemptive Therapy for Myeloid Neoplasms After Allogeneic Stem Cell Transplantation.
Clin Lymphoma Myeloma Leuk
; 20(6): 377-382, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32234295